Voloridge Investment Management, LLC Nektar Therapeutics Transaction History

Voloridge Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $558,810 - $1.09 Million	176,281 Added 1132.84%	191,842 $729,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $64,733 - $213,496	15,561 New	15,561 $84,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $4.23 Million - $6.51 Million	-255,628 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $1.27 Million - $1.54 Million	80,794 Added 46.21%	255,628 $4.35 Million
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $2.43 Million - $3.63 Million	146,495 Added 516.94%	174,834 $2.9 Million
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $477,795 - $664,266	28,339 New	28,339 $656,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $2.37 Million - $3.46 Million	-149,472 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $966,998 - $2.07 Million	57,185 Added 61.96%	149,472 $2.72 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $2.86 Million - $3.35 Million	92,287 New	92,287 $3.28 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $10.2 Million - $15 Million	-323,645 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $9.85 Million - $18.3 Million	323,645 New	323,645 $10.6 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $106,375 - $240,235	-2,300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $8.74 Million - $16.5 Million	-152,264 Reduced 98.51%	2,300 $244,000
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $3.56 Million - $9.35 Million	154,564	154,564 $9.23 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $171M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.